William G. Kaelin, Jr., MD

2020 Plenary Keynote: Tackling Undruggable Oncoproteins: Lessons from the VHL Tumor Suppressor Protein

William G. Kaelin, Jr., MD

Professor and Investigator, Howard Hughes Medical Institute, Oncology, Dana-Farber Cancer Institute

A Nobel laureate, Dr. Kaelin received the 2019 Nobel Prize in Physiology or Medicine. Dr. Kaelin is a member of the American Society of Clinical Investigation, the American College of Physicians, the National Academy of Sciences and the National Academy of Medicine.


Our Commitment to Community

As the coronavirus situation further develops, the health and well-being of our community remains our top priority. We would never have dreamt our world would be facing such uncertain times. Our team has been working for months behind the scenes planning the 2020 event.


2019 Featured Speakers

John Doench, PhD
Broad Institute of Harvard and MIT

Bryan Fuchs, PhD
Ferring Research Institute

Nathanael S. Gray, PhD
Dana-Farber Cancer Institute

Stephen J. Haggarty, PhD
Harvard Medical School & Massachusetts General Hospital

Cory M. Hogaboam, PhD
Cedars-Sinai Medical Center

Paul A. Insel, MD
University of California, San Diego

Ian James, PhD
Trevena, Inc.

Elliott Nickbarg, PhD
Merck & Co, Inc.

Andrew Nixon, PhD
Boehringer Ingelheim

J. Brad Shotwell, PhD

Rebecca Taub, MD
Madrigal Pharmaceuticals

Peter M. Tessier, PhD
University of Michigan

Shaomeng Wang, PhD
University of Michigan

Kevin Weeks, PhD
University of North Carolina

Join the Discovery on Target Community

Discovery on Target (DOT) is the industry’s preeminent event on novel drug targets and technologies for drug discovery professionals. DOT highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents, ranging from biologics to small molecules.

We aim to meet your research needs. At DOT, you can travel across numerous concurrent sessions and customize your experience further through comprehensive training seminars, focused short courses, interactive roundtable discussions, and engaging networking functions.

Our 2020 event is expanding to 20 conference programs including new topics on proteomicssmall G proteins, disease modeling, preclinical oncology models and tools, CNS, gene and cell therapy, and biomarkers, plus lead and candidate selection for therapeutic proteins and modality selection for next-generation biotherapeutics to continue our growing coverage of biologics.

Over 1,100 international peers will convene for our 18th annual event in the biotech hub that is Boston, MA on September 15-18, 2020. We welcome you to join our community and be part of our 2020 event!

Event at a Glance
Brochure Download
See Who's Attending

Premier Sponsors